Lifeboat Foundation

And ArsTechnica seems to be totally missing the point as “delaying” Starship for SOUND AND PRACTICAL SAFETY AND ENVIRONMENTAL QUESTIONS is not ‘delaying’ progress and one needs to simply ask why SpaceX “engineers” can’t up their game enough to actually answer or address those legitimate questions? The answer is rather simple, they probably CAN but the person “in charge” has no with to, incentive to, or will to do so because he sees anyone that questions him as ‘unreasonable opposition’ rather than legitimate concern. Starship could crash and burn on the orbital flight and it would not make a difference at all to the ‘world’ in general. We can and have recovered from worse numerous times while advancing technology and transportation. The FACT that Musk, (and his many rapid fans) somehow “assume” that he and only he can ‘advance’ space access are very much proof that this is not about engineering, ability or purpose but strictly about ego.

To the FAA, Musk seemed to be saying, federal regulators must do their part to ensure the future arrives on schedule. Just as the 20th-century skyscrapers marked the beginning of a new era and eventually launched America into a prosperous future of finance, communication, marketing, and more, the 21st century now beckons.

The skyscraper age will soon give way to the space age.

Continue reading “With a single photo, SpaceX sent a not-so-subtle message to FAA regulators” »

International Health Management, Across 17 Countries, 60 Clinics, and 350 Staff — Dr. James Allen, Health Systems Thinkers, LLC.

Dr. James Allen is a primary care internal medicine specialist who developed a fascinating career in international health management and leadership.

Continue reading “Dr. James Allen — Global Health Systems Thought Leader — Health Systems Thinkers, LLC” »

Private sector solutions to major social problems — stephanie smith — director, humanitarian & development, mastercard.

Stephanie Smith is a Director, in the Humanitarian & Development group, at Mastercard (https://www.mastercard.us), the American multinational financial services corporation.

Continue reading “Stephanie Smith — Director, Humanitarian & Development, Mastercard” »

Wiliot, a company developing Bluetooth-enabled sensors for tracking and analytics, has raised $200 million in venture capital.

French Gates and Scott, who were formerly married to Seattle-based tech founders Bill Gates and Jeff Bezos, respectively, have become powerful philanthropists in their own rights. Both women, who are among the richest people in the world, have signed The Giving Pledge, promising to give away the majority of their wealth in their lifetimes.

In a powerful philanthropic pairing, Melinda French Gates and McKenzie Scott have teamed up to direct $40 million to advancing the power and influence of American women over the next decade.

The donation is being awarded to winners of the Equality Can’t Wait Challenge, a competition hosted by French Gates’ investment firm Pivotal Ventures, with financial support from Scott and her husband, Dan Jewett, as well as from the Charles and Lynn Schusterman Family Philanthropies. The challenge billed itself as “the first competition centered on gender and equality in the U.S. with an award of this magnitude and … an opportunity to invest in and empower women leaders.”

Continue reading “Melinda French Gates and McKenzie Scott team up to give $40 million to support women” »

Big shift in the making.

✅ Want to maximize your business banking? Check out NorthOne*: https://get.northone.com/minoritymindset/
*This is an advertisement. Minority Mindset is compensated by NorthOne.

Continue reading “Unemployment Crisis — 40% Of Americans Are About To QUIT Their Jobs” »

A company that makes an implantable brain-computer interface (BCI) has been given the go-ahead by the Food and Drug Administration to run a clinical trial with human patients. Synchron plans to start an early feasibility study of its Stentrode implant later this year at Mount Sinai Hospital, New York with six subjects. The company said it will assess the device’s “safety and efficacy in patients with severe paralysis.” https://www.engadget.com/fda-brain-computer-interface-clinic…ml?src=rss

A company that makes an implantable has been given the go-ahead by the Food and Drug Administration to run a clinical trial with human patients. Synchron plans to start an early feasibility study of its Stentrode implant later this year at Mount Sinai Hospital, New York with six subjects. The company said it will assess the device’s “safety and efficacy in patients with severe paralysis.”

Synchron received the FDA’s green light ahead of competitors like Elon Musk’s. Before such companies can sell BCIs commercially in the US, they need to prove that the devices work and are safe. The FDA will provide guidance for trials of BCI devices for patients with paralysis or amputation during a webinar on Thursday.

Continue reading “FDA clears Synchron’s brain-computer interface device for human trials” »

The science and technology of growing young — sergey young, founder, longevity vision fund.

Sergey Young (https://sergeyyoung.com/) is a longevity investor, visionary, and author, with a mission to help one billion people extend their healthy lifespans by making longevity affordable and accessible for everyone. As part of this mission, he is the Founder of the Longevity Vision Fund (LVF — https://lvf.vc/), a $100 Million venture capital fund that invests in technologies with the potential to disrupt life sciences and healthcare to help people live longer and healthier lives.

Continue reading “Sergey Young — Founder, Longevity Vision Fund — Longevity Venture Partner, BOLD Capital Partners” »

India has undeniable strengths, too, of course. Its computing and commercial talent makes it natural territory for venture capital. The potential to spawn game-changing startups is there. But the money flowing into venture capital worldwide is not really seeking originality. Like a Hollywood producer, it prefers to back variants of ideas that have already been hits. India is a decent story, but only a few will make decent money from it. The numbers just don’t add up.

The formula for success cannot simply be copied across from America or China | Finance & economics.